Search research articles
Contact Us
Filters
Showing results (241-250 of 376) with videos related to
Page
of 38
Sort By:
Dermatology and Therapy
|
May 17, 2026
Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial
Melinda Gooderham, Christopher G Bunick, JiaDe Yu, et al.
The Journal of Dermatological Treatment
|
June 28, 2021
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy
Peter A Lio, Eric L Simpson, George Han, et al.
American Journal of Clinical Dermatology
|
October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
Lisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
Advances in Therapy
|
November 1, 2022
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
Andrew Blauvelt, Andreas Wollenberg, Lawrence F Eichenfield, et al.
Paediatric Drugs
|
May 24, 2023
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
Michael A Haft, Helen H Park, Stephanie S Lee, et al.
Journal of the American Academy of Dermatology
|
July 30, 2023
A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study
Stephanie S Lee, Anshika Kaushik, Nicola Natsis, et al.
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo
Lawrence A Schachner, Anneke Andriessen, Latanya T Benjamin, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age
Leon H Kircik, Julie C Harper, Hilary Baldwin, et al.
The Journal of Dermatological Treatment
|
November 10, 2024
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
Andreas Wollenberg, Masanori Ikeda, Chia-Yu Chu, et al.
The Journal of Pediatrics
|
August 5, 2006
Congenital localized scleroderma
Francesco Zulian, Cristina Vallongo, Sheila Knupp Feitosa de Oliveira, et al.
Page
of 38
Search research articles
Search
Showing results (241-250 of 376) with videos related to
Sort By:
Page
of 38
Dermatology and Therapy
|
May 17, 2026
Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial
Melinda Gooderham, Christopher G Bunick, JiaDe Yu, et al.
The Journal of Dermatological Treatment
|
June 28, 2021
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy
Peter A Lio, Eric L Simpson, George Han, et al.
American Journal of Clinical Dermatology
|
October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
Lisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
Advances in Therapy
|
November 1, 2022
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
Andrew Blauvelt, Andreas Wollenberg, Lawrence F Eichenfield, et al.
Paediatric Drugs
|
May 24, 2023
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
Michael A Haft, Helen H Park, Stephanie S Lee, et al.
Journal of the American Academy of Dermatology
|
July 30, 2023
A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study
Stephanie S Lee, Anshika Kaushik, Nicola Natsis, et al.
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo
Lawrence A Schachner, Anneke Andriessen, Latanya T Benjamin, et al.
Journal of Drugs in Dermatology : JDD
|
December 2, 2025
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age
Leon H Kircik, Julie C Harper, Hilary Baldwin, et al.
The Journal of Dermatological Treatment
|
November 10, 2024
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
Andreas Wollenberg, Masanori Ikeda, Chia-Yu Chu, et al.
The Journal of Pediatrics
|
August 5, 2006
Congenital localized scleroderma
Francesco Zulian, Cristina Vallongo, Sheila Knupp Feitosa de Oliveira, et al.
Page
of 38